Literature DB >> 7762433

Primary and three-dimensional structure of lactotransferrin (lactoferrin) glycans.

G Spik1, B Coddeville, J Mazurier, Y Bourne, C Cambillaut, J Montreuil.   

Abstract

In order to establish relationships between glycan structure and biological activity, the authors undertook a comparative study of the glycan primary structure of different transferrins from several species. By associating permethylation-mass spectrometry and 1H-NMR spectroscopy, the primary structure of the human, bovine, caprine, murine and porcine lactotransferrin glycans were determined. Using the same methods, the glycan structure of 9 serotransferrins was determined. The results obtained led to the conclusion that glycans are specific for each transferrin and, for a given transferrin, specific to the species. No relationship could be established between primary structure and function of transferrin glycans. Glycan molecular modelling, molecular dynamics simulations and X-ray diffraction studies of free glycans confirm the mobility in space of antennae. In contrast, the glycan associated with a protein is immobilized into only one conformation, as in the case of glycan-lectin associations or of "internal" glycan-protein interactions, like in rabbit serotransferrin, in which the glycan forms a bridge between the two lobes of the peptide chain, and maintains the protein in a biologically active conformation. In the case of human sero- and lactotransferrins, the glycans are in an external position on the molecules and could play a role of recognition signals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7762433     DOI: 10.1007/978-1-4615-2548-6_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Isolated rat hepatocytes differentially bind and internalize bovine lactoferrin N- and C-lobes.

Authors:  M P Sitaram; D D McAbee
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  Characterization of the sugar-binding specificity of the toxic lectins isolated from Abrus pulchellus seeds.

Authors:  M V Ramos; A H Sampaio; B S Cavada; J J Calvete; T B Grangeiro; H Debray
Journal:  Glycoconj J       Date:  2001-05       Impact factor: 2.916

4.  Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk.

Authors:  Geun-Cheol Gil; William H Velander; Kevin E Van Cott
Journal:  Glycobiology       Date:  2008-05-02       Impact factor: 4.313

Review 5.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 6.  Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide.

Authors:  K E Van Cott; P E Monahan; T C Nichols; W H Velander
Journal:  Haemophilia       Date:  2004-10       Impact factor: 4.287

7.  N-glycosylation microheterogeneity and site occupancy of an Asn-X-Cys sequon in plasma-derived and recombinant protein C.

Authors:  Geun-Cheol Gil; William H Velander; Kevin E Van Cott
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

8.  Protein-Linked Glycan Degradation in Infants Fed Human Milk.

Authors:  David C Dallas; David Sela; Mark A Underwood; J Bruce German; Carlito Lebrilla
Journal:  J Glycomics Lipidomics       Date:  2012-05-01

Review 9.  Studying Lactoferrin N-Glycosylation.

Authors:  Sercan Karav; J Bruce German; Camille Rouquié; Annabelle Le Parc; Daniela Barile
Journal:  Int J Mol Sci       Date:  2017-04-20       Impact factor: 5.923

Review 10.  Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants.

Authors:  Hans Demmelmair; Christine Prell; Niklas Timby; Bo Lönnerdal
Journal:  Nutrients       Date:  2017-07-28       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.